Cargando…
Preclinical Evaluation of (18)F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors
PURPOSE: We investigated 2-(5-fluoro-pentyl)-2-methyl-malonic acid ((18)F-ML-10) positron emission tomography (PET) imaging of apoptosis posttherapy to determine optimal timing for predicting chemotherapy response in a mouse head/neck xenograft cancer model. PROCEDURES: BALB/c nude mice (4-8 weeks o...
Autores principales: | Demirci, Emre, Ahmed, Rafay, Ocak, Meltem, Latoche, Joseph, Radelet, April, DeBlasio, Nicole, Mason, N. Scott, Anderson, Carolyn J., Mountz, James M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469516/ https://www.ncbi.nlm.nih.gov/pubmed/28654376 http://dx.doi.org/10.1177/1536012116685941 |
Ejemplares similares
-
[(18)F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment
por: Oborski, Matthew J., et al.
Publicado: (2016) -
Apoptotic PET Imaging of Rat Pulmonary Fibrosis With
[(18)F]ML-8
por: Xiong, Ying, et al.
Publicado: (2018) -
Almost Complete Response with a Single Administration (225)Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary
por: Alan Selçuk, Nalan, et al.
Publicado: (2022) -
[(18)F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
por: Jouberton, Elodie, et al.
Publicado: (2020) -
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy
por: Oborski, Matthew J, et al.
Publicado: (2014)